About Genetesis
Genetesis is a company based in Mason (United States) founded in 2013 by Emmanuel Setegn, Vineet Erasala, and Peeyush Shrivastava. Genetesis has raised $35.48 million across 6 funding rounds from investors including Wilson Sonsini Goodrich & Rosati, Mithril and Cercano Management. The company has 28 employees as of December 31, 2024. Genetesis offers products and services including CardioFlux and CardioFlux Membership.
- Headquarter Mason, United States
- Employees 28 as on 31 Dec, 2024
- Founders Emmanuel Setegn, Vineet Erasala, Peeyush Shrivastava
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Genetesis, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$35.48 M (USD)
in 6 rounds
-
Latest Funding Round
$17.5 M (USD), Series C
Oct 06, 2022
-
Investors
Wilson Sonsini Goodrich & Rosati
& 11 more
-
Employee Count
28
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Genetesis
Genetesis offers a comprehensive portfolio of products and services, including CardioFlux and CardioFlux Membership.
Non-invasive tool for early detection of myocardial ischemia in hospitals.
Program offering access to preventive cardiac care tools and resources.
People of Genetesis
Unlock access to complete
Unlock access to complete
Funding Insights of Genetesis
Genetesis has successfully raised a total of $35.48M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $17.5 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Genetesis
Genetesis has secured backing from 12 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Wilson Sonsini Goodrich & Rosati, Mithril and Cercano Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are made in the UK and US.
|
Locked | Locked | Locked | |
|
Early-stage sector-agnostic VC firm investing in geographies such as the US
|
Locked | Locked | Locked | |
|
CincyTech is engaged in venture capital investments for innovative startups.
|
Locked | Locked | Locked |
Investor details for Genetesis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Genetesis
Investment portfolio details for Genetesis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Genetesis
Detailed financials for Genetesis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Genetesis Comparisons
Peer comparison for Genetesis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Genetesis
Detailed competitors of Genetesis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Genetesis
Complete news archive for Genetesis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genetesis
Genetesis was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Genetesis is headquartered in Mason, United States. It is registered at Mason, Ohio, United States.
Peeyush Shrivastava is the current CEO of Genetesis. They have also founded this company.
Genetesis is a funded company, having raised a total of $35.48M across 6 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Genetesis is 28.
Genetesis was founded in 2013 and is headquartered in Mason, United States. The company operates in the medical imaging sector, focusing on cardiac diagnostics. A device named CardioFlux is being developed to utilize magnetocardiography for measuring the hearts natural magnetic fields. This technology aids in the non-invasive assessment of cardiac conditions, with operations centered on device innovation and clinical applications.
Genetesis offers CardioFlux and CardioFlux Membership.
Genetesis has 12 investors. Key investors include Wilson Sonsini Goodrich & Rosati, Mithril, Cercano Management, JobsOhio, and Ohio Innovation Fund.